Introduction: Selective hepatic arterial embolization (HAE) with polyvinyl alcohol particles has been shown to be equivalent to chemoembolization for patients with hepatic gastroenteropancreatic (GEP) neuroendocrine metastases. There remains debate about its clinical effectiveness and which patients benefit from treatment.
Aim(s): We reviewed the demographics, disease distribution and response to treatment of patients with GEP hepatic pre-dominant metastases undergoing HAE between 2008 and 2012.
Materials and methods: Data was collected on the type of primary, size and number of liver metastases and presence of extra-hepatic disease. Response to treatment was evaluated by biochemical (reduction in urine 5-HIAA), radiological (contrast CT) and clinical (patient-reported symptoms) methods.
Conference: 10th Annual ENETS Conference 2013 (2013)
Presenting Author: Mr Colin Wilson
To read results and conclusion, please login ...
Further abstracts you may be interested in